Every 10-Q that QT IMAGING HOLDINGS WTS (QTIWW) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow QTIWW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full QTIWW filings page.
QT Imaging Holdings, Inc., a medical device company focused on breast imaging systems, reported strong top-line growth but continued losses for the three and six months ended June 30, 2026. Revenue was $7.4 million for the quarter and $14.0 million year‑to‑date, compared with $3.7 million and $6.5 million in 2025, driven almost entirely by U.S. product sales.
Gross profit rose to $3.1 million for the quarter; however, higher research and development and selling, general and administrative expenses led to a loss from operations of $1.9 million for the quarter and $4.2 million year‑to‑date. Non‑operating items were significant: a $8.3 million loss on debt extinguishment and modification related to the Lynrock Lake term loan and $1.7 million of interest expense contributed to a net loss of $11.1 million for the quarter and $14.5 million for six months.
Cash and cash equivalents were $10.9 million at June 30, 2026, with operating cash outflows of $8.5 million in the first half. Long‑term debt increased to $11.4 million after extending the Lynrock Lake term loan to March 31, 2029 at 12% interest. Stockholders’ equity declined to $2.2 million as liabilities reached $28.4 million against $30.6 million of assets.
QT Imaging uplisted to the Nasdaq Capital Market on January 28, 2026 and raised additional equity through PIPE transactions and a May 2026 underwritten public offering that generated approximately $8.9 million in net proceeds. The company signed distribution agreements with NXC Imaging, Gulf Medical Co., and Al Naghi Medical Co. that include minimum order quantities totaling 195 scanners from 2026 to 2028, representing potential revenue of more than $103 million over that period, supported by recent regulatory approvals in Saudi Arabia and the UAE. Management believes current cash, credit facilities, and expected revenues will fund operations for at least 12 months, while acknowledging ongoing losses and the need for additional capital over time.
QT Imaging Holdings, Inc. reported sharply higher revenue and a smaller loss for the quarter ended March 31, 2026. Revenue rose to $6.5 million from $2.8 million a year earlier, driven almost entirely by product sales in the United States.
Gross profit increased to $2.7 million, but higher research and development plus selling, general and administrative expenses pushed the operating loss to $2.3 million. Net loss narrowed to $3.4 million from $11.1 million, helped by lower other expenses.
Cash and cash equivalents were $6.9 million, with cash used in operating activities of $3.7 million in the quarter. Total liabilities were $18.2 million and stockholders’ equity fell to $3.8 million from $6.4 million, reflecting ongoing losses and fair value changes in warrant and earnout liabilities.
The company highlighted distribution agreements with minimum order quantities that it believes, together with the Lynrock Lake Term Loan (now maturing in 2029 at 12% interest), PIPE financings, and expected MOQ-related revenue, will fund its operating plan for at least the next 12 months.
QT Imaging Holdings (QTIH) reported Q3 results showing higher sales but continued losses. Revenue reached $4,192,101 versus $955,970 a year ago, with gross profit of $1,802,673. Operating loss was $1,652,079 and net loss was $4,557,406. For the nine months, revenue was $10,649,930 and net loss totaled $19,694,921.
Cash and restricted cash were $1,735,400 at quarter‑end, while total liabilities were $21,197,385, resulting in a stockholders’ deficit of $9,076,444. The company completed financings including a senior secured term loan (initially $10.1 million, amended to $15.1 million with Tranche B) and an October 2025 private placement providing gross proceeds of $18,180,655 at $4.50 per share. A 3‑for‑1 reverse stock split became effective October 23, 2025. Customer concentration remained high, with Customer A accounting for 99% of Q3 revenue. Management cites minimum order quantities under U.S. and Saudi Arabia distribution agreements as expected support for future cash flows.